Home
NewsNewsWith ART Fertility Clinics now part of its network, IVI RMA Global has created a Middle East operating region to meet growing fertility needs. The integration boosts treatment capacity, scientific output, and care consistency across the UAE and Saudi Arabia as demographic pressures shape demand for assisted reproduction
IVI RMA Global has named the Middle East as its newest operating region after acquiring ART Fertility Clinics, a move that marks an important step in the IVI RMA Global expansion into fast-growing reproductive markets. The integration covers ART Fertility’s established operations in the UAE and its planned entry into Saudi Arabia, extending the company’s network beyond North America, Italy, Northern Europe, Iberia, Latam, and Czechia. Led by CEO Suresh Soni and Medical Director Dr. Human M. Fatemi, the move positions the combined platform to serve tens of thousands of patients across the region.
The expansion comes as the Middle East faces declining fertility rates, with World Bank data showing the UAE at 1.2 births per woman and continued declines in Saudi Arabia. Dr. Fatemi said, “Across the Middle East, there is a growing awareness of the importance of addressing fertility challenges directly, and we are seeing more individuals and couples seeking advanced solutions every day,” adding that ART Fertility’s integration will accelerate scientific progress and raise care standards. The acquisition strengthens the IVI RMA Global expansion strategy by bringing more than 300 clinicians, embryologists, and geneticists into its network, supported by proprietary research and protocols that have delivered pregnancy rates as high as 71% across multiple age groups.
Soni noted, “The entire ART Fertility team is excited about this combination of two leaders in global fertility meeting the fertility challenge in the Middle East,” highlighting opportunities to deepen clinical value and research output. ART Fertility’s scientific footprint stretches across major R&D investments, more than 268 peer-reviewed papers, 35 ongoing studies, and 11 conferences. Together, these efforts have helped cement its role as a reference point in reproductive medicine. These capabilities align with the broader IVI RMA Global expansion effort aimed at advancing fertility science and strengthening clinical practice across the region.
Javier Sánchez Prieto, CEO of IVI RMA Global, said, “We are always looking for quality organizations that meet our high standards and whose own success can strengthen our work,” emphasizing the expectation that demand for fertility care in the Middle East will continue to grow. The acquisition places IVI RMA in a strong position to lead scientific and clinical advancements throughout the region.
The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.
Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.
La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.
IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.
Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.
Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.
The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.
